These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 25698233

  • 1. A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.
    Ramos-Álvarez I, Mantey SA, Nakamura T, Nuche-Berenguer B, Moreno P, Moody TW, Maderdrut JL, Coy DH, Jensen RT.
    Peptides; 2015 Apr; 66():26-42. PubMed ID: 25698233
    [Abstract] [Full Text] [Related]

  • 2. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 3. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 4. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 5. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM, Riherd DN, O'Malley BW.
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [Abstract] [Full Text] [Related]

  • 6. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 7. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.
    Langer I, Latek D.
    Front Endocrinol (Lausanne); 2021 Feb; 12():711906. PubMed ID: 34867774
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC1 receptor.
    Tasma Z, Rees TA, Guo S, Tan S, O'Carroll SJ, Faull RLM, Curtis MA, Christensen SL, Hay DL, Walker CS.
    Br J Pharmacol; 2024 Aug; 181(15):2655-2675. PubMed ID: 38616050
    [Abstract] [Full Text] [Related]

  • 9. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.
    Jaworski DM.
    Cell Tissue Res; 2000 May; 300(2):219-30. PubMed ID: 10867818
    [Abstract] [Full Text] [Related]

  • 10. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
    Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B.
    J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876
    [Abstract] [Full Text] [Related]

  • 11. Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury.
    Broome ST, Mandwie M, Gorrie CA, Musumeci G, Marzagalli R, Castorina A.
    J Mol Neurosci; 2023 Oct 02; 73(9-10):724-737. PubMed ID: 37646964
    [Abstract] [Full Text] [Related]

  • 12. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Busto R, Sánchez-Chapado M, Guijarro LG, Prieto JC.
    Cell Signal; 1999 Nov 02; 11(11):813-9. PubMed ID: 10617284
    [Abstract] [Full Text] [Related]

  • 13. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
    Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI.
    J Comp Neurol; 2004 Aug 30; 476(4):388-413. PubMed ID: 15282712
    [Abstract] [Full Text] [Related]

  • 14. Structural motifs of pituitary adenylate cyclase-activating polypeptide (PACAP) defining PAC1-receptor selectivity.
    Schäfer H, Zheng J, Morys-Wortmann C, Fölsch UR, Schmidt WE.
    Regul Pept; 1999 Feb 05; 79(2-3):83-92. PubMed ID: 10100920
    [Abstract] [Full Text] [Related]

  • 15. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
    Sághy É, Payrits M, Helyes Z, Reglődi D, Bánki E, Tóth G, Couvineau A, Szőke É.
    Neuroscience; 2015 Nov 12; 308():144-56. PubMed ID: 26321242
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G.
    Endocrinology; 2002 Apr 12; 143(4):1253-9. PubMed ID: 11897681
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.
    Moody TW, Nuche-Berenguer B, Jensen RT.
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb 12; 23(1):38-47. PubMed ID: 26702849
    [Abstract] [Full Text] [Related]

  • 18. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.
    Mol Cell Neurosci; 2006 Feb 12; 31(2):193-209. PubMed ID: 16226889
    [Abstract] [Full Text] [Related]

  • 19. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV, Olesen J.
    Neuropeptides; 2014 Apr 12; 48(2):53-64. PubMed ID: 24508136
    [Abstract] [Full Text] [Related]

  • 20. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B.
    J Comp Neurol; 2006 Jun 01; 496(4):468-78. PubMed ID: 16572459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.